English 中文简体 中文繁体
World-class Technology Platforms

In complex diseases, such as cancer and viral infection, multiple signaling pathways or mechanisms are involved. For cancer treatments, combinations of two therapeutic antibodies with different mechanisms of action have been shown to be more effective than individual monotherapy. However, dual therapies significantly increase the cost burden to society, and there are more potential complications of combining and administering two drugs at the clinic. 


At Alphamab Oncology, we have developed two proprietary technical approaches to provide innovative solutions to address this growing trend in the development of modern biotherapeutics.